Electromed, Inc. Files 2024 10-K

TL;DR

Electromed filed its 2024 10-K. Full financials and biz ops for FY ending 6/30/24 are in.

AI Summary

Electromed, Inc. filed its 10-K for the fiscal year ending June 30, 2024, reporting on its operations in the electromedical and electrotherapeutic apparatus industry. The company's principal executive offices are located at 500 Sixth Avenue NW, New Prague, MN 56071. The filing covers the period from July 1, 2023, to June 30, 2024, and includes financial data for the fiscal years ending June 30, 2024, 2023, and 2022.

Why It Matters

This 10-K filing provides a comprehensive overview of Electromed, Inc.'s financial performance and business operations for the fiscal year 2024, offering insights for investors and stakeholders.

Risk Assessment

Risk Level: medium — This filing is a standard annual report and does not inherently contain new risks beyond those typically associated with publicly traded companies.

Key Numbers

• 06/30/2024 — Fiscal Year End (Reporting period for the 10-K)
• 07/01/2023 - 06/30/2024 — Fiscal Year (Period covered by the report)
• 001-34839 — SEC File Number (Electromed's SEC registration number)

Key Players & Entities

• Electromed, Inc. (company) — Filer of the 10-K
• 500 Sixth Avenue NW, New Prague, MN 56071 (location) — Business and mailing address
• June 30, 2024 (date) — Fiscal year end
• June 30, 2023 (date) — Previous fiscal year end
• June 30, 2022 (date) — Prior fiscal year end

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share ELMD NYSE American LLC
• $235 million — U.S. market for HFCWO was approximately $235 million in 2023 growing at an 8% compound annua

Filing Documents

• elmd240883_10k.htm (10-K) — 931KB
• elmd240883_ex10-23.htm (EX-10.23) — 6KB
• elmd240883_ex19.htm (EX-19) — 67KB
• elmd240883_ex23-1.htm (EX-23.1) — 3KB
• elmd240883_ex24-1.htm (EX-24.1) — 36KB
• elmd240883_ex31-1.htm (EX-31.1) — 15KB
• elmd240883_ex31-2.htm (EX-31.2) — 14KB
• elmd240883_ex32-1.htm (EX-32.1) — 5KB
• elmd240883_ex32-2.htm (EX-32.2) — 5KB
• elmd240883_ex97.htm (EX-97) — 39KB
• a240883img001.jpg (GRAPHIC) — 48KB
• 0000897101-24-000422.txt ( ) — 5142KB
• elmd-20240630.xsd (EX-101.SCH) — 37KB
• elmd-20240630_cal.xml (EX-101.CAL) — 44KB
• elmd-20240630_def.xml (EX-101.DEF) — 124KB
• elmd-20240630_lab.xml (EX-101.LAB) — 337KB
• elmd-20240630_pre.xml (EX-101.PRE) — 254KB
• elmd240883_10k_htm.xml (XML) — 624KB

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 12 Item 1B. Unresolved Staff Comments 12 Item 1C. Cybersecurity 12 Item 2. Properties. 13 Item 3. Legal Proceedings. 13 Item 4. Mine Safety Disclosures. 13 PART II 13 Item 5. Market For Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 13 Item 6. [Reserved]. 14 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations. 14 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk. 20 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data. F-1 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure. 21 Item 9A.

Controls and Procedures

Controls and Procedures. 21 Item 9B. Other Information. 22 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 22 PART III 22 Item 10. Directors, Executive Officers and Corporate Governance. 22 Item 11.

Executive Compensation

Executive Compensation. 23 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 23 Item 13. Certain Relationships and Related Transactions, and Director Independence. 23 Item 14. Principal Accountant Fees and Services. 23 PART IV 23 Item 15. Exhibits and Financial Statement Schedules. 23 Item 16. Form 10-K Summary. 26 i INFORMATION REGARDING FORWARD-LOOKING STATEMENTS contained in this Annual Report on Form 10-K that are not statements of historical fact should be considered forward-looking statements within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward- looking statements include, but are not limited to, statements regarding: our business strategy, including our intended level of investment in research and development and marketing activities; our expectations with respect to earnings, gross margins and sales growth, industry relationships, marketing strategies and international sales; estimated sizes of markets into which our products are or may be sold; our business strengths and competitive advantages; our ability to grow additional sales distribution channels; our intent to retain any earnings for use in operations rather than paying dividends; our expectation that our products will continue to qualify for reimbursement and payment under government and private insurance programs; our intellectual property plans and practices; the expected impact of applicable regulations on our business; our beliefs about our manufacturing processes; our expectations and beliefs with respect to our employees and our relationships with them; our belief that our current facilities are adequate to support our growth plans; our expectations with respect to ongoing compliance with the terms of our credit facility; our expectations regarding the ongoing availability of credit and our

View Full Filing

View this 10-K filing on SEC EDGAR